Metabolic syndrome as a risk factor for gallstone disease. - Wikidata - wikimedia - TriplyDB

Metabolic syndrome as a risk factor for gallstone disease.

Metabolic syndrome as a risk factor for gallstone disease.

http://www.wikidata.org/entity/Q30420193

about

Epidemiology of gallbladder disease: cholelithiasis and cancer Epidemiology, management, and economic evaluation of screening of gallstone disease among type 2 diabetics: A systematic review The association between gallstones and metabolic syndrome in urban Han Chinese: a longitudinal cohort study Factors affecting metabolic syndrome by lifestyle.Serum insulin, insulin resistance, beta-cell dysfunction, and gallstone disease among type 2 diabetics in Chinese population: a community-based study in Kinmen, Taiwan.Serum leptin levels and insulin resistance are associated with gallstone disease in overweight subjects.Low serum levels of ghrelin are associated with gallstone disease.Fatty liver, carotid disease and gallstones: a study of age-related associations The association of metabolic syndrome and its factors with gallstone disease.The number of metabolic abnormalities associated with the risk of gallstones in a non-diabetic population.Prevalences of and risk factors for biliary stones and gallbladder polyps in a large Chinese population Metabolic syndrome and gallstone disease The metabolic syndrome is associated with complicated gallstone disease Insulin resistance as a risk factor for gallbladder stone formation in Korean postmenopausal women Insulin resistance is associated with gallstones even in non-obese, non-diabetic Korean men A genomewide search finds major susceptibility loci for gallbladder disease on chromosome 1 in Mexican Americans.Independent effects of cardiorespiratory fitness, vigorous physical activity, and body mass index on clinical gallbladder disease risk Spontaneous gallbladder pathology in baboons ApoB-100, ApoE and CYP7A1 gene polymorphisms in Mexican patients with cholesterol gallstone disease.Gallbladder gallstone disease is associated with newly diagnosed coronary artery atherosclerotic disease: a cross-sectional study.Disruption of the murine protein kinase Cbeta gene promotes gallstone formation and alters biliary lipid and hepatic cholesterol metabolism Association of cholecystectomy with metabolic syndrome in a Chinese population.A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study.Personal history of gallstones and risk of incident psoriasis and psoriatic arthritis in U.S. women.Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease.Gallstone is correlated with an increased risk of idiopathic sudden sensorineural hearing loss: a retrospective cohort study.Pregnancy is not a risk factor for gallstone disease: results of a randomly selected population sample Current views on genetics and epigenetics of cholesterol gallstone disease Correlations between metabolic syndrome, serologic factors, and gallstones Incidence of gallstone disease in Italy: results from a multicenter, population-based Italian study (the MICOL project).Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol.The association between gallstone disease and plaque in the abdominopelvic arteries.An observational study on the association of nonalcoholic fatty liver disease and metabolic syndrome with gall stone disease requiring cholecystectomy.Increased Risk of Gallstone Disease Following Colectomy for Ulcerative Colitis.Prospective Study of Glycemic Load, Glycemic Index, and Carbohydrate Intake in Relation to Risk of Biliary Tract Cancer.Prevalence and complications of gallstone disease among pregnant women in a Nigerian hospital.Gallstone disease is associated with arterial stiffness progression.Laparoscopic cholecystectomy for gallbladder disease in patients with severe cardiovascular disease.Quantitative analysis of gallstones in Libyan patients Hormone replacement therapy and symptomatic gallstones - a prospective population study in the EPIC-Norfolk cohort.

P2860

Q24629433-8A440821-3A43-40F8-8BD0-450A907AE16B Q26798423-C5DFCD3D-D656-42B1-8B23-7C160A06CFF2 Q30378222-F06D0361-F1BF-4CC0-82F2-F7383DF9F9E9 Q30388825-C434A6C7-C869-4C08-8587-4E3D888FBD1B Q30393149-F324D6C6-F26F-4001-998C-9B9F003FF248 Q30411805-B6FA66C6-4799-422D-BD39-D20E508FF2AB Q30433017-F22524D7-EE4D-4C3A-AF3E-63E1CC00ED5B Q30433376-0BCFE6F6-3174-4398-83FD-A36DDB054A0A Q30433531-99207CA6-F84C-4EFE-B77A-648BA721662E Q30441933-5D7ECE9A-1C7F-473C-8588-D72206B8FBEC Q30454023-74C9605B-A0FC-4AC8-A3A0-11F88A05B9B0 Q30464508-F936F13D-0AF3-4D99-91A9-B1E8760D0961 Q30467969-42FFFD0A-1316-4644-A088-07A98F3535CF Q30473662-EC883FC2-6F1D-4F0B-9CDC-345EE1D185EA Q30492754-228355FD-2DDB-4C37-864D-081E22CDC8F9 Q30498786-07F24C73-AA62-4EB0-8EC7-D7F81BDA2672 Q33709878-2DE50F93-BDE8-43AA-A391-F998F449512C Q33823199-98CCAE36-D9DD-44BE-9CE0-5D2343BB2697 Q34183183-869F31A7-4230-4FA9-B57A-7A6DDCABAABB Q34995083-0167E206-1BD2-4A0D-A165-24B21452ED0E Q35067675-ABD84AAB-95C5-4E84-80E9-CFC4BD2A3DF2 Q35088582-FC61E39A-CF81-4214-A306-6A5B6061C72B Q35107146-3976220E-E2AE-40E8-9271-F49D3494649B Q35370653-14BD4655-D658-4453-A101-22F0C6002EBA Q36116709-74EFE8B7-8575-400F-98DB-606C07A72C4B Q36120554-1AD71392-E565-471C-A109-76FD7288345E Q36496665-B1558633-4A50-44D9-BCFC-ADB90A4EDE2D Q36829866-F04E2046-3480-4A3E-99F4-77EBF44D4F4F Q37232538-8096D349-F811-4217-BF03-08DA990E8D30 Q37347047-A14D3C17-ABF4-4C02-9424-F9A832EDC1CC Q37718735-50149E16-4F4A-4270-B7AE-D04D2EEF2E26 Q37721973-A96BA4E4-CF24-4601-A834-426E925F6820 Q37725233-F376CD97-A74E-4108-85A7-4A10AFC475EA Q38403163-65BE60E7-599C-43EB-9A2D-258FBD978FEA Q39884001-6D52EA2E-496C-448C-B2E5-36066FC29E8F Q40162942-CFADA2EC-6365-4433-A6CD-87D80D120B9C Q40563764-26F173CB-F73C-4212-90D9-FD381FF472E7 Q42621073-FC356622-0F17-40FD-BBDD-D816739C8722 Q42706010-2CAC5C97-5C86-49AA-AF40-910FE7602738 Q44213527-FC62DDA2-7EFB-4061-8D2D-E7FE1D350B98

P2860

Metabolic syndrome as a risk factor for gallstone disease.

http://www.wikidata.org/entity/Q30420193

description

2005 nî lūn-bûn

@nan

2005 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մարտին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Metabolic syndrome as a risk factor for gallstone disease.

@ast

Metabolic syndrome as a risk factor for gallstone disease.

@en

type

label

Metabolic syndrome as a risk factor for gallstone disease.

@ast

Metabolic syndrome as a risk factor for gallstone disease.

@en

prefLabel

Metabolic syndrome as a risk factor for gallstone disease.

@ast

Metabolic syndrome as a risk factor for gallstone disease.

@en

P1433

Q30420193-59518F5B-F253-43BE-933C-6338DD8F6A33

P1476

Q30420193-FE1D5ACD-AA8E-4B7A-81D1-0543513F0D73

P2093

Q30420193-0A3362A6-0AA5-48E5-98D4-AC2F2054EFA6

Q30420193-1479A71D-DF89-4820-A899-7DA341655CCC

Q30420193-285EC8E9-2413-4DFC-852D-6EF01C658BB9

Q30420193-2E2447CD-9E33-49C6-A1F6-A4C80A08B300

Q30420193-49F93C5A-E6D3-477C-997A-358F3BF0CD49

Q30420193-5FEDBD57-BD8E-4ED4-9F81-6BAE52C93ED5

P2860

Q30420193-000C8EF1-BA61-4A17-9015-BFBE5BB29FB4

Q30420193-00BB1806-F4D6-424D-9EE7-91F17CD3CA60

Q30420193-012DDF33-8D2A-4EC2-90A2-060BB96A6E4B

Q30420193-11976C3E-D387-4647-8300-9F469602273B

Q30420193-24A98C97-C6BF-4EA9-A2F2-90B440E2ED4E

Q30420193-397FAF5E-E831-4347-9E99-C3D8D8D09426

Q30420193-3BE9703B-3CEB-416B-B256-5B7190EAF207

Q30420193-3E77A1CA-F1D7-454A-A989-4EB4DEDE3C25

Q30420193-4ED1AD80-01FD-4C7E-AE6B-47A7DD23121B

Q30420193-50BCC817-6615-4807-B2D1-3359B3CD4777

P304

Q30420193-329D6395-6A30-4BA6-89FC-C8B03856B00F

P31

Q30420193-21CA4BB6-A8DD-47F5-8B31-3A1C817437E2

P356

Q30420193-4244C816-86B1-4526-8FCB-F15AC1353794

P407

Q30420193-DC66CB0D-232D-4778-BFE6-D864C1AEDEAD

P433

Q30420193-57BA05B0-E3F4-423C-8ED7-6ABBC4BAA42C

P478

Q30420193-D4B7F55B-87EC-4058-BEA3-4DD2130FECF8

P50

Q30420193-B3DB9C12-3047-49FC-8C53-138EA4E8F549

Q30420193-DA9E59BD-C5FA-4CEF-8C26-57D122AEAD26

P577

Q30420193-C26166B5-130F-4758-A3E5-2A9625EA2A8A

P5875

Q30420193-23FDC9AA-2EED-453A-B38A-109FC2AD650D

P698

Q30420193-982DF3A8-7E6F-43C0-B0F0-317F4CEDF1CE

P921

Q30420193-0960C088-8A02-4CFB-8450-E338041990C5

Q30420193-2A40A6AF-C05B-42B2-9D2E-B99EE43ADB1E

P932

Q30420193-A68D50A8-D0B8-4AAC-B3D5-15082B3BF8C9

P356

WJG.V11.I11.1653

P1433

World Journal of Gastroenterology

P1476

Metabolic syndrome as a risk factor for gallstone disease.

@en

P2093

Daniel Motola-Kuba

http://www.w3.org/2001/XMLSchema#string

Guadalupe Ponciano-Rodríguez

http://www.w3.org/2001/XMLSchema#string

Héctor Baptista

http://www.w3.org/2001/XMLSchema#string

Karla Sanchez-Lara

http://www.w3.org/2001/XMLSchema#string

Martha H Ramos

http://www.w3.org/2001/XMLSchema#string

Nahum Méndez-Sánchez

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence and Trends in Obesity Among US Adults, 1999-2000

Obesity and insulin resistance

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Banting lecture 1988. Role of insulin resistance in human disease

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

Gall stones in a Danish population. Relation to weight, physical activity, smoking, coffee consumption, and diabetes mellitus.

Risk factors for gall-bladder disease: a cohort study of young women attending family planning clinics

The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease.

Plasma lipids and insulin in gall stone disease: a case-control study

P304

1653-1657

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V11.I11.1653

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Norberto Carlos Chávez-Tapia

P577

2005-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7948355

http://www.w3.org/2001/XMLSchema#string

P698

15786544

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome

P932

4305948

http://www.w3.org/2001/XMLSchema#string